INSIGHTS ON DRUG DEVELOPMENT

• Modifying The Micro-Environment To Improve Dissolution Rate

  <p>Discover how modifying the micro-environment with targeted excipients can significantly enhance the dissolution rate of poorly soluble drugs using conventional manufacturing methods.</p>

• Formulation Development For Therapeutic Oligonucleotides

  Discover how expert formulation and analytical support enable the development of stable, injectable oligonucleotide therapies across diverse delivery routes and molecule types.

• EMA Support For Rare Disease Therapies

  Review how the EMA supports rare disease drug development through regulatory and financial incentives for therapies that meet strict eligibility and ongoing compliance criteria.

• The Role Of A Consulting Firm In The IND Process

  Navigate the complex IND process with expert guidance and discover how early FDA engagement can accelerate your path to clinical trials.

• Choosing The Right PBMCS For Your Research And Product Development Needs

  6/10/2025

  Enhance the success of your research and cell therapy programs by sourcing PBMCs with proven functional performance and donor-specific insights.

• Flow Chemistry Vs. Batch Processes

  6/10/2025

  Explore how continuous flow chemistry can accelerate your chemical development with greater efficiency, safety, and sustainability compared to traditional batch processes.

• Linking Clinical Correlates To Cell Therapy Outcomes

  6/9/2025

  Streamline cell therapy development by transforming complex cellular characteristics into a predictive, multiparametric metric that guides the selection of high-potential starting material.

• Injection Site Reaction Screening Methodology

  6/6/2025

  Optimize drug formulations for solubility at physiological pH to reduce injection site reactions, enable high-concentration dosing, and enhance patient comfort and compliance.